Hospital
DVH Hospital Alliance LLC
DVH Hospital Alliance LLC was paid $12.78M by Medicaid between Jan 2018 and Dec 2024, across 163 billing codes. Its largest line is 99285, emergency room visit (most serious) — 21% of everything it billed.
33Billing provider infoDVH HOSPITAL ALLIANCE LLC
PAHRUMP, NV 89048
PAHRUMP, NV 89048
33aNPI1073963138assigned 06/20/2016
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.78M
24GClaims512,001
24DCodes billed163
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Nevada
Rank by total paid#16 of 36
Median peer was paid$7.64M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,731 | $1.70M | |
| 2019 | 77,006 | $1.81M | |
| 2020 | 64,448 | $1.59M | |
| 2021 | 69,915 | $1.91M | |
| 2022 | 81,460 | $2.00M | |
| 2023 | 83,894 | $2.13M | |
| 2024incomplete | 75,547 | $1.65M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 21,285 | 16,752 | $2.70M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 16,013 | 13,800 | $2.12M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 14% | 4,284 | 3,477 | $1.85M |
| G0378 | Hospital observation service, per hour | 14% | 5,013 | 1,895 | $1.78M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 8.4% | 3,220 | 2,757 | $1.07M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.3% | 15,831 | 14,147 | $1.06M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3.8% | 1,260 | 1,039 | $486K |
| 72125 | Computed tomography, cervical spine; without contrast material | 3.7% | 1,770 | 1,527 | $471K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2.3% | 1,527 | 1,284 | $300K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.8% | 2,608 | 2,277 | $226K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 5,491 | 4,547 | $165K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 3,318 | 2,984 | $60K |
151 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 6,363 | $54K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 15,445 | $54K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 844 | $40K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 986 | $32K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16,273 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 20,278 | $20K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,365 | $18K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 11,096 | $18K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 798 | $12K |
| 77066 | Tomosynthesis, mammo | <1% | 80 | $12K |
| 93971 | <1% | 162 | $11K | |
| J3490 | Unclassified drugs | <1% | 8,295 | $10K |
| 80053 | Comprehensive metabolic panel | <1% | 30,617 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,600 | $8K |
| 96376 | <1% | 5,593 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 5,156 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 33,266 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,017 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 18,255 | $7K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 458 | $7K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 36 | $7K |
| 76642 | <1% | 536 | $7K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 876 | $7K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 644 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,984 | $6K |
| 76830 | Ultrasound, transvaginal | <1% | 64 | $5K |
| 84484 | <1% | 22,524 | $5K | |
| 83880 | <1% | 7,483 | $5K | |
| 94060 | <1% | 37 | $4K | |
| 71250 | <1% | 103 | $4K | |
| 72100 | <1% | 271 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,663 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 70 | $3K |
| 97162 | <1% | 44 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,112 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,263 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,450 | $3K |
| 73562 | <1% | 653 | $2K | |
| 99070 | <1% | 17 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 18 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 34,639 | $2K |
| 73630 | <1% | 597 | $2K | |
| 78454 | <1% | 34 | $2K | |
| 85730 | <1% | 13,820 | $2K | |
| 83735 | <1% | 12,427 | $2K | |
| 83690 | <1% | 9,610 | $2K | |
| 73130 | <1% | 680 | $2K | |
| 84703 | <1% | 7,673 | $2K | |
| 83605 | <1% | 7,432 | $2K | |
| 82553 | <1% | 7,022 | $2K | |
| 72131 | <1% | 27 | $2K | |
| 94664 | <1% | 3,339 | $2K | |
| 73610 | <1% | 688 | $2K | |
| 73030 | <1% | 656 | $2K | |
| 80050 | General health panel | <1% | 121 | $1K |
| 81000 | <1% | 16,732 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 43 | $1K |
| 85610 | <1% | 14,464 | $1K | |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $1K |
| 82550 | <1% | 9,509 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,272 | $1K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 572 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,935 | $1K |
| 90715 | <1% | 702 | $1K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 3,269 | $976.41 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,321 | $964.42 |
| 87040 | <1% | 2,027 | $700.65 | |
| 73110 | <1% | 170 | $683.81 | |
| 80061 | Lipid panel | <1% | 1,524 | $634.94 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,412 | $594.55 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,238 | $463.22 |
| 0450 | Emergency room services | <1% | 13 | $457.23 |
| 84702 | <1% | 781 | $456.39 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 117 | $455.64 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,757 | $450.40 |
| 70486 | <1% | 15 | $448.88 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 33 | $435.95 |
| 82803 | <1% | 600 | $423.63 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 101 | $372.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,374 | $360.18 |
| 85378 | <1% | 1,586 | $355.61 | |
| 87070 | <1% | 1,505 | $342.82 | |
| 87430 | <1% | 1,200 | $263.01 | |
| 86756 | <1% | 575 | $246.64 | |
| 87088 | <1% | 958 | $221.15 | |
| 36600 | <1% | 523 | $170.65 | |
| 94727 | <1% | 36 | $155.70 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 997 | $147.51 |
| 94762 | <1% | 544 | $143.36 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 65 | $140.66 |
| 93015 | <1% | 35 | $133.84 | |
| 94761 | <1% | 1,888 | $109.81 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 83 | $96.07 |
| 94644 | <1% | 90 | $96.06 | |
| 51702 | <1% | 41 | $83.71 | |
| 77080 | <1% | 12 | $82.42 | |
| 96368 | <1% | 191 | $72.20 | |
| 80329 | <1% | 1,848 | $60.17 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 257 | $55.30 |
| 87186 | <1% | 191 | $54.02 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 157 | $52.63 |
| 73590 | <1% | 44 | $49.18 | |
| 73080 | <1% | 20 | $48.79 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 560 | $47.46 |
| J1094 | Injection, dexamethasone acetate, 1 mg | <1% | 67 | $29.11 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,252 | $27.88 |
| 96367 | <1% | 192 | $26.69 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,529 | $26.32 |
| 51701 | <1% | 29 | $26.08 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 249 | $25.13 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 94 | $22.81 |
| 87077 | <1% | 213 | $22.08 | |
| 74018 | <1% | 29 | $18.54 | |
| 82150 | <1% | 166 | $17.81 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 259 | $17.43 |
| 86901 | <1% | 159 | $16.47 | |
| 82272 | <1% | 75 | $11.17 | |
| 86140 | <1% | 120 | $10.86 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 83 | $8.71 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 90 | $6.08 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 227 | $5.85 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 20 | $4.80 |
| 85652 | <1% | 41 | $3.83 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 98 | $3.50 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 201 | $2.44 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 114 | $2.40 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 89 | $1.81 |
| 82962 | <1% | 141 | $1.23 | |
| J1815 | Injection, insulin, per 5 units | <1% | 20 | $1.15 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 214 | $1.08 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 30 | $0.27 |
| 82565 | 0% | 67 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 140 | $0.00 |
| 01999 | 0% | 30 | $0.00 | |
| S0028 | Injection, famotidine, 20 mg | 0% | 111 | $0.00 |
| 84439 | 0% | 29 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 53 | $0.00 |
| S0164 | Injection, pantoprazole sodium, 40 mg | 0% | 29 | $0.00 |
| 84520 | 0% | 67 | $0.00 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 197 | $0.00 |
| 94729 | 0% | 37 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 19 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 18 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 71 | $0.00 |
| 80320 | 0% | 3,503 | $0.00 | |
| 86850 | 0% | 34 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 52 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 26 | $0.00 |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 0% | 71 | $0.00 |
| 84132 | 0% | 40 | $0.00 | |
| 12001 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.